CUTR News and Press, Cutera Inc. From 03/24/23

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&#...

2023-03-16 17:24:42 ET Gainers: Hub Cyber Security ( HUBC ) +6% . Altimmune ( ALT ) +5% . Hawaiian Holdings ( HA ) +4% . MacroGenics ( MGNX ) +3% . PENN Entertainment ( PENN ) +3% . Losers: Sarepta Therapeutics ( NASDAQ...

Award-winning body sculpting duo introduces a bold new look CUTERA, INC. (Nasdaq: CUTR) a leading provider of aesthetic and dermatology solutions, is proud to reveal the refreshed truBody brand. This award-winning treatment pairs two clinically proven technologies for a customized, conv...

2023-03-07 10:42:35 ET Summary The key negatives for Cutera, Inc. are that its 2023 revenue guidance was below expectations, and the future performance of its aesthetic solutions might be affected by the weak economic environment. Cutera's key positives relate to the strong revenu...

Cutera, Inc. (CUTR) Q4 2022 Earnings Conference Call February 28, 2023 04:30 PM ET Company Participants Dave Mowry - Chief Executive Officer Rohan Seth - Chief Financial Officer Conference Call Participants Jon Block - Stifel Margaret Kaczor - William Blair...

Gainers Lionheart III Corp ( LION ) +23% . Sarepta Therapeutics, Inc. ( SRPT ) +16% . Schrodinger, Inc. ( SDGR ) +12% . Mount Rainier Acquisition Corp. ( RNER ) +11% . eHealth, Inc. ( EHTH ) +9% . Losers: Novavax, Inc. ( NVAX )...

Cutera press release ( NASDAQ: CUTR ): Q4 GAAP EPS of -$0.40 misses by $0.02 . Revenue of $67.4M (+2.7% Y/Y) misses by $2.12M . Full-year 2023 revenue outlook of $277 million to $292 million. The consensus estimate is $305M. For further details see: Cuter...

Full-year 2022 revenue of $252.4 million, growing 16% in constant currency Placed greater than 600 AviClear devices during 2022, and generated $4.5M in AviClear revenue in 2022 Full-year 2023 revenue outlook of $277 million to $292 million, implying 10% to 16% constant currency gr...

Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year of 2022 after the market close on Tuesday, February 28, 2...

Summary AirSculpt Technologies has potential to be a niche operator in a crowded space of human plastics. Since listing, shares have crumbled, as investors re-rated the stock heavily to the downside. However, the re-rating looks more than justified, and we demonstrate that future gr...